47 results
Page 2 of 3
F-6
EX-99
08zscjzblb
30 Oct 12
Registration for ADRs (foreign)
12:00am
6-K
42uz5rkltltv05jtaj9
8 Aug 12
Current report (foreign)
12:00am
6-K
kiaf2j03s1he9crjth
8 Mar 12
Teva Receives FDA Approval for ProAirĀ® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
EX-2.1
ettraim
3 May 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
5klyo89re1
8 Jan 10
Fda Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
12:00am
6-K
rwgggp7 8nlxida6gtj2
7 Jan 10
Fda Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
12:00am
6-K
k745oma1
14 Dec 09
Fda Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
12:00am
6-K
EX-99.1
oxev0
6 Nov 08
Teva Reports Third Quarter 2008 Results
12:00am
F-4/A
y34x8
14 Oct 08
Registration of securities (foreign) (amended)
12:00am
6-K
cml0dxq2vygmi4w9
24 Sep 08
Teva???s Proair? Hfa, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication - Printer Friendly Version
12:00am
F-4
c7kno5p6fv8umwspv
16 Sep 08
Registration of securities (foreign)
12:00am
6-K
EX-2
d660kx8g
18 Jul 08
Report of Foreign Private Issuer
12:00am
425
EX-2.1
vke8mk3 bzo59c134dz
18 Jul 08
Business combination disclosure
12:00am
6-K
rwu5rb83
23 May 08
Current report (foreign)
12:00am